| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Cardlytics (NASDAQ:CDLX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 7 | 0 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 4 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $14.86, a high estimate of $18.00, and a low estimate of $12.00. Observing a 7.22% increase, the current average has risen from the previous average price target of $13.86.
The perception of Cardlytics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Kyle Peterson | Needham | Maintains | Buy | $12.00 | $12.00 |
| Jason Kreyer | Craig-Hallum | Lowers | Buy | $12.00 | $18.00 |
| Kyle Peterson | Needham | Lowers | Buy | $12.00 | $17.00 |
| Kyle Peterson | Needham | Raises | Buy | $17.00 | $15.00 |
| Jacob Stephan | Lake Street | Raises | Buy | $18.00 | $13.00 |
| Jason Kreyer | Craig-Hallum | Raises | Buy | $18.00 | $10.00 |
| Kyle Peterson | Needham | Raises | Buy | $15.00 | $12.00 |
To gain a panoramic view of Cardlytics's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Cardlytics analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Cardlytics's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 5.09%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Net Margin: Cardlytics's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -35.91%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Cardlytics's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -14.54%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Cardlytics's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -4.25%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Cardlytics's debt-to-equity ratio stands notably higher than the industry average, reaching 1.34. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CDLX
